12:00 AM
Jan 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Alzumab itolizumab regulatory update

Biocon said India's Drugs Controller General of India (DCGI) approved Alzumab itolizumab to treat chronic plaque psoriasis. The company plans to launch the humanized IgG1 mAb that inhibits CD6 in the country later this...

Read the full 157 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >